______________________

Cangen Biotechnologies, Inc. is a cancer-focused biotechnology company developing non-invasive diagnostic tests for early detection of cancer, chemosensitivity technologies to enhance the selection of cancer therapeutic regimes as well as targeted drug and biologic cancer therapies, including vaccines. The company is currently enrolling patients in a Phase 3 study to evaluate a molecular diagnostic test for the early detection of bladder cancer, based on microsatellite DNA instability.


Cangen Biotechnologies is headquartered in Bethesda, MD, has laboratories in Rockville, MD and conducts additional research at JohnsHopkinsUniversity in Baltimore, MD. The company has a clinical trial center in Seoul, Korea and operations in Tokyo, Japan. Cangen is on the world wide web at www.cangenbio.com.


Olympus Corporation is a global precision technology leader in designing and delivering solutions for medical and healthcare, imaging and information, and industrial applications. Olympus leverages research and development investment in technology and manufacturing processes across various business lines which include:

* Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
* Advanced clinical and research microscopes;
* Lab automation systems, chemistry-immuno and blood analyzers and reagents;
* Digital and film cameras and digital voice recorders; and
* Information processing equipment, industrial video scopes, and industrial microscopes.

Back to HCB News

More Voices